Navigation Links
The Most Common Cause of Hair Loss Is the Least Suspected, Warns Trichology Expert
Date:4/21/2009

COSTA MESA, Calif., April 21 /PRNewswire/ -- In the United States, one of the most common causes of hair loss often goes undetected: hyperhydrosis, also known as hyperhidrosis, or excessive sweating. Erkkie Harris-Wells, who diagnoses and treats hair and scalp ailments in her role as trichologist and founder of the Miyohara International Trichology Clinic (http://www.miyoharainternational.com), stated, "Hyperhydrosis accounts for about 70 percent of hair loss cases for both males and females. While European physicians are accustomed to this type of diagnosis, most American doctors are unaware of the link between hyperhydrosis and hair damage. It can't be treated with a drug like Rogaine. I'm even writing an article to alert hair transplant surgeons to the ways in which hyperhydrosis can compromise their restoration procedures."

Sweating is a generally healthy mechanism in which sweat glands help remove impurities and cool the body down from overheating. "But excessive sweating can be harmful to the hair and scalp because of the lactic acid in our sweat secretions," explained Harris-Wells. The acid strips away the epithelial sheath, which is the outer protective layer of the hair. As a result, hair loses volume and density, and it becomes porous and dry to the point of brittleness. The excess acid can also cause inflammation of the scalp, and if untreated can produce red, sore pustules that will become infected with bacteria. Harris-Wells has treated both genders, from adults to children, for this condition.

"The most notable form of hyperhydrosis is excessive sweating in the hands, feet, underarms and face," she said. "For example, people with thyroid problems may not outwardly sweat but still undergo the internal chemical processes that lead to lactic acid being secreted onto the scalp and hair."

Hyperhydrosis cases range from mild to severe in terms of hair loss. Sufferers can include hair transplant patients, men and women with hormonal imbalances, avid gym-goers, sports figures and athletes, highly stressed individuals, and people with medical conditions that are genetic.

Harris-Wells' clinic is expanding its line of products formulated to counteract the effects of hyperhydrosis as well as other forms of hair loss conditions. Harris-Wells can diagnose out-of-state individuals who send her hair samples and a copy of their last medical exam. She will also refer them to appropriate medical practitioners as needed.

For more information on circumstances leading to hair loss from hyperhydrosis, visit http://www.miyoharainternational.com/hair_loss_hyperhydrosis.html.

About Miyohara International Trichology Clinic

Based in Costa Mesa, Calif., Miyohara International Trichology Clinic sets itself apart from other hair-replacement clinics by identifying each client's form or type of hair loss, expelling the guesswork and ensuring the success rate of any scalp or hair-loss disorder. Through trichology, hair samples are microscopically examined, and a program is custom-designed around the diagnosis to prevent further hair loss and restore it to health. Most Miyohara patients experience over 90 percent success rate without using products such as Rogaine, which can have serious side effects and is effective in only 35 percent of hair loss cases. Instead, the clinic uses the most advanced products available to treat hair loss appropriately.

Photos of microscopic analysis of hair:

http://www.ereleases.com/pr/2009-Miyohara.jpg

http://www.ereleases.com/pr/2009-Miyohara2.jpg

Additional photos are available at http://www.miyoharainternational.com/hair_loss.html.

    Contact:

    Erkkie Harris-Wells
    Founder, Miyohara International Trichology Clinic
    (714) 210-2488
    miyoharaintl@aol.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Miyohara International Trichology Clinic
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Canadian Medical Device Set to Speed Treatment and Cut Health Care Costs for Common Cause of Vertigo
2. Silent Heart Attacks More Common Than Thought
3. Mayo Clinic-led researchers confirm gene variants associated with the most common adult leukemia
4. All Persons Who Purchased or Acquired the Common Stock of Sunrise Senior Living, Inc. (Sunrise) Between February 26, 2004 and July 28, 2006, Inclusive, and Were Damaged Thereby (The Class)
5. Tianyin Pharmaceutical Co., Inc. Series A Preferred Shareholders Approved Cash Dividend to Common Stockholders
6. Common Industrial Chemicals May Not Boost Cancer Risk
7. New Hair Product Line Addresses Common Scalp Conditions of Teens and Tweens
8. Authentidate Buys Back Shares of its Common Stock
9. Novavax Announces Closing of $11 Million Common Stock Sale to Subsidiary of Cadila Pharmaceuticals
10. Drug commonly used for alcoholism, drug addiction, curbs urges of compulsive stealers
11. New Device Treats Common Heart Rhythm Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 28, 2017 , ... Resoundant, Inc., the developer of ... Healthineers annual customer education symposium, a world-class learning conference that offers educational content ... - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , Innovations ...
(Date:3/28/2017)... ... March 29, 2017 , ... The Thyroid ... Isabella Wentz, Pharm.D., FASCP. The program was recently launched on March 1, and ... regarding thyroid function. , Dr. Izabella Wentz is a licensed pharmacist and ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... share of all holidays (IBT World Travel Trends Report). As travelers visit both ... a range in temperatures, and prolonged sun exposure. In response, the outdoor industry ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the science and clinical practice of radiosurgery, announced today the publication of ... observational registry established to standardize data collection from patients treated with stereotactic ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Alert Sentry ... of MPERS (Mobile Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These ... market. The first of their kind, the iSAFE and iSAFE Plus offer direct GPS ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... March 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... for the fourth quarter and year ended December 31, ... of transformational progress for Orexigen, beginning with the re-acquisition ... Commencing early March, the team at Orexigen demonstrated remarkable ... which reshaped and strengthened our Company while rewarding us ...
(Date:3/28/2017)... BOSTON , March 28, 2017  Market ... today announced a partnership with premium news content ... pharmaceutical companies to extract key insights from Dow ... mining technology. The Linguamatics I2E platform ... 20 global pharmaceutical companies. The Linguamatics-Dow Jones partnership ...
(Date:3/28/2017)... 28, 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... Medicines Agency (EMA) has notified the company that ... Authorisation Application (MAA) has passed validation, and that ... The MAA for ARX-04 (known as DSUVIA™ in ...
Breaking Medicine Technology: